Kaplan-Meier survival analysis associates AIMP protein family with outcomes in glioblastoma and lower-grade gliomas, suggesting therapy response variation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Noor et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: